51 Biggest Movers From Yesterday

Gainers

• Sunshine Biopharma, Inc. (NASDAQ:SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.
• Anghami Inc. (NASDAQ:ANGH) gained 47.5% to close at $13.41.
• Dingdong (Cayman) Limited (NYSE:DDL) shares jumped 46% to close at $6.86.
• Inozyme Pharma, Inc. (NASDAQ:INZY) surged 38.6% to close at $5.96 after the company announced preliminary data from its Phase 1/2 trial of INZ-701 in patients with ENPP1 deficiency.
• Tantech Holdings Ltd (NASDAQ:TANH) gained 31.3% to close at $0.6655.
• Kaspien Holdings Inc. (NASDAQ:KSPN) jumped 28.9% to close at $9.50.
• Celsion Corporation (NASDAQ:CLSN) rose 26.4% to close at $6.22 after Zack's Small Cap Research and Brookline set bullish price targets on the stock.
• BT Brands, Inc. (NASDAQ:BTBD) gained 25.5% to settle at $3.10.
• FG Financial Group, Inc. (NASDAQ:FGF) jumped 24.4% to settle at $3.5950 following a 13G filing from Peter Lynch showing a new 5.83% stake in the company
• System1, Inc. (NYSE:SST) gained 23% to settle at $20.31 as the company reported a 48% year-over-year surge in Q4 sales and issued strong sales forecast.
• Spirit Airlines, Inc. (NYSE:SAVE) jumped 22.4% to close at $26.92 following an NYT report suggesting JetBlue has made a $3.6 billion offer for the company.
• Helix Acquisition Corp. (NASDAQ:HLXA) gained 19.8% to close at $13.25.
• Energy Vault Holdings, Inc. (NYSE:NRGV) jumped 18.9% to close at $21.64.
• Ensysce Biosciences, Inc. (NASDAQ:ENSC) climbed 18.8% to close at $1.33. Ensysce Biosciences recently posted a Q4 loss of $0.45 per share.
• BigBear.ai Holdings, Inc. (NYSE:BBAI) gained 18.3% to close at $10.34.
• Sphere 3D Corp (NASDAQ:ANY) gained 16.6% to settle at $2.53. Sphere 3D and Gryphon Digital Mining 'plan to continue working on existing strategic initiatives, including the management of Sphere 3D's 6.0 EH/s mining fleet' following mutual agreement not to move forward with merger.
• Nam Tai Property Inc. (NYSE:NTP) climbed 16.4% to close at $7.33.
• Compass Therapeutics, Inc. (NASDAQ:CMPX) gained 16.3% to close at $1.86.
• Bone Biologics Corporation (NASDAQ:BBLG) surged 16% to close at $3.04.
• CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) gained 14.7% to close at $0.3797. CNS Pharmaceuticals received approval from Competent Authority of Switzerland for potentially pivotal study of berubicin for treatment of glioblastoma multiforme.
• Worksport Ltd. (NASDAQ:WKSP) jumped 13.6% to close at $3.25.
• Singularity Future Technology Ltd. (NASDAQ:SGLY) jumped 13.6% to close at $17.00.
• Recon Technology, Ltd. (NASDAQ:RCON) gained 11.2% to close at $1.19 following 13D filing from co-founder, Shenping Yin, showing raised stake in the company from 12% to 50%.
• Allego N.V. (NYSE:ALLG) gained 10.6% to close at $13.40.
• Asure Software, Inc. (NASDAQ:ASUR) climbed 8.5% to close at $6.74.
• Arcus Biosciences, Inc. (NASDAQ:RCUS) climbed 8.1% to settle at $37.73. Arcus Biosciences will replace Investors Bancorp in the S&P SmallCap 600 effective Thursday, April 7.
• Lucira Health, Inc. (NASDAQ:LHDX) gained 6.9% to close at $3.90.

Don’t forget to check out our premarket coverage here .

Losers

• Nutex Health Inc. (NASDAQ:NUTX) shares dipped 33.4% to close at $26.64 on Tuesday. Clinigence Holdings and Nutex Health, on Monday, reported completion of merger and listing on the Nasdaq Capital Market.
• Cognyte Software Ltd. (NASDAQ:CGNT) shares dipped 31.1% to close at $8.03 after the company reported worse-than-expected Q4 EPS and sales results.
• IMARA Inc. (NASDAQ:IMRA) shares fell 22.1% to close at $1.27 after the company said interim results in ardent trial for sickle cell disease showed no significant difference in median annualized rate of vaso-occlusive crises.
• Immix Biopharma, Inc. (NASDAQ:IMMX) dipped 22% to close at $2.02. The company’s management discussed key milestones, drug development timelines and the IMMX Advantage at its Milestone Day Event held on April 5, 2022.
• Zosano Pharma Corporation (NASDAQ:ZSAN) fell 20.3% to close at $0.1610. Zosano Pharma recently said it is looking at strategic alternatives and reduced 31% of its staff as the FDA rejected its already-rejected migraine drug last month.
• Cassava Sciences, Inc. (NASDAQ:SAVA) dropped 18.8% to close at $31.23.
• Integrated Media Technology Limited (NASDAQ:IMTE) fell 18.4% to $29.06.
• GWG Holdings, Inc. (NASDAQ:GWGH) fell 17.1% to close at $3.50.
• C4 Therapeutics, Inc. (NASDAQ:CCCC) dipped 16.8% to close at $22.00.
• Precipio, Inc. (NASDAQ:PRPO) fell 16.7% to close at $1.40 after surging around 22% on Monday.
• Castle Biosciences, Inc. (NASDAQ:CSTL) dropped 16.5% to close at $38.40. Castle Biosciences agreed to acquire AltheaDx Inc, a commercial-stage molecular diagnostics company, for $140 million, including milestone payment.
• Digital World Acquisition Corp. (NASDAQ:DWAC) fell 15.7% to close at $48.00 amid Elon Musk taking a 9.2% stake in competitor Twitter.
• BRC Inc. (NYSE:BRCC) dipped 14.8% to close at $24.10 after Raymond James downgraded the stock from Outperform to Market Perform.
• SAB Biotherapeutics, Inc. (NASDAQ:SABS) dropped 13.8% to close at $2.81.
• Dolphin Entertainment, Inc. (NASDAQ:DLPN) fell 13.6% to close at $4.69.
• Vivos Therapeutics, Inc. (NASDAQ:VVOS) fell 12.8% to close at $1.83. Vivos Therapeutics recently posted Q4 sales of $4.40 million.
• Direct Digital Holdings, Inc. (NASDAQ:DRCT) declined 12.5% to close at $3.21.
• Takung Art Co., Ltd. (NASDAQ:TKAT) dropped 11.8% to close at $3.44.
• Xponential Fitness, Inc. (NYSE:XPOF) shares fell 11.1% to close at $21.02 as the company reported a public offering of 4.5 million shares of the common stock by selling stockholders.
• SmartRent, Inc. (NYSE:SMRT) dipped 10.9% to close at $4.81.
• GameStop Corp. (NYSE:GME) dropped 10% to close at $153.59.
• Carvana Co. (NYSE:CVNA) dropped 8.7% to close at $121.46 as RBC Capital downgraded the stock from Outperform to Sector Perform and lowered its price target from $155 to $138.
• Acuity Brands, Inc. (NYSE:AYI) dropped 8.1% to close at $170.12 following Q2 results.
• GBS Inc. (NASDAQ:GBS) fell 7.6% to close at $1.21 after jumping 68% on Monday. Zacks Small-Cap Research, on Monday, issued a note on GBS with an $8 valuation.